Enforcement Report - Week of February 4, 2026
04 Feb 2026 //
FDA
FDA Issues Form 483 to Baxter Oncology
05 Nov 2025 //
FDA
Enforcement Report - Week of September 3, 2025
03 Sep 2025 //
FDA
Health Canada Issues Recalls of Baxter`s NaCl injection
06 Jun 2025 //
HEALTH CANADA
Enforcement Report - Week of November 13, 2024
13 Nov 2024 //
FDA
Enforcement Report - Week of September 11, 2024
11 Sep 2024 //
FDA
Baxter Issues Urgent Medical Device Recall for Life2000 Ventilator
10 Jul 2024 //
FDA
Enforcement Report - Week of February 28, 2024
28 Feb 2024 //
FDA
FDA Issues Form 483 to Baxter Pharmaceuticals India
31 Jan 2024 //
FDA
Enforcement Report - Week of December 13, 2023
13 Dec 2023 //
FDA
Enforcement Report - Week of October 25, 2023
25 Oct 2023 //
FDA
Health Canada Issues Recall of Baxter`s Sodium Chloride Injections: Solution bags may be leaking in affected lots.
03 Oct 2023 //
HEALTH CANADA
Health Canada Issues Recall of Baxter`s 5% Dextrose Injection, USP: Solution bags may be leaking in affected lots
03 Oct 2023 //
HEALTH CANADA
Health Canada Issues Recall of Baxter`s Gentamicin(E) Sulfate: Solution bags may be leaking in affected lots
03 Oct 2023 //
HEALTH CANADA
Health Canada Issues Recall of Baxter`s Metronidazole Injection, USP: Solution bags may be leaking in affected lots
03 Oct 2023 //
HEALTH CANADA
Baxter Pharmaceuticals India Pvt. Ltd. on Health Canada Inspection List
12 Sep 2023 //
HEALTH CANADA
Enforcement Report - Week of September 6, 2023
06 Sep 2023 //
FDA
Baxter Healthcare Corporation Receives FDA Warning Letter
02 Aug 2023 //
FDA
Health Canada Issues Recall of Baxter`s Sodium Chloride Injections
20 Jul 2023 //
HEALTH CANADA
Health Canda Issues Recall of Baxter Corporation`s 0.9% Sodium chloride inj; Bags leaking
05 May 2023 //
HEALTH CANADA
Enforcement Report - Week of August 24, 2022
24 Aug 2022 //
FDA
Health Canada Issues Recall of Baxter Corporation Heparin Sodium and 0.9% Sodium Chloride Injection
08 Feb 2022 //
HEALTH CANADA
Enforcement Report - Week of November 18, 2020
18 Nov 2020 //
FDA
Health Canada Issues Recall of Baxter Corporation`s Dianeal PD4 CAPD
15 Nov 2019 //
FDA
Enforcement Report - Week of July 31, 2019
31 Jul 2019 //
FDA
Health Canada Issues Recall of Baxter Corporation Extraneal solution
24 Mar 2019 //
HEALTH CANADA
Enforcement Report - Week of January 16, 2019
16 Jan 2019 //
FDA
Enforcement Report - Week of November 14, 2018
14 Nov 2018 //
FDA
Enforcement Report - Week of October 3, 2018
03 Oct 2018 //
FDA
Enforcement Report - Week of September 26, 2018
26 Sep 2018 //
FDA
Enforcement Report - Week of September 5, 2018
05 Sep 2018 //
FDA
Enforcement Report - Week of February 7, 2018
07 Feb 2018 //
FDA
US FDA Issues Form 483 to Baxter Healthcare Corporation (Drug Manufacturer)
15 Dec 2017 //
FDA
Baxter Corporation Recalls Dianeal PD4 CAPD Solution With 1.5% Dextrose And 2.5meq/L Calcium
16 Nov 2017 //
HEALTH CANADA
Enforcement Report - Week of November 1, 2017
01 Nov 2017 //
FDA
Enforcement Report - Week of July 19, 2017
19 Jul 2017 //
FDA
Enforcement Report - Week of May 24, 2017
24 May 2017 //
FDA
US FDA Enforcement Report- 1/June/2016
31 May 2016 //
FDA
US FDA Enforcement Report- 18/May/2016
17 May 2016 //
FDA
Baxter IV Solutions: Recall - Potential Presence of Particulate Matter
07 Jan 2016 //
FDA
Recall: Baxter`s Clinimix (2015-06-19)
12 Jun 2015 //
HEALTHY CANADIANS
Baxter Initiates Class I Recall of Sodium Chloride Injection
18 Apr 2015 //
FDA
Baxter Initiates Voluntary Recall Due to the Presence of Particulate Matter
13 Apr 2015 //
FDA
Baxter recalls more than half a million units of saline
08 Apr 2015 //
FIERCE PHARMA MANUFACTURING

Market Place
Sourcing Support